Cargando…
Correction to: Co‑clinical FDG‑PET radiomic signature in predicting response to neoadjuvant chemotherapy in triple‑negative breast cancer
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803622/ https://www.ncbi.nlm.nih.gov/pubmed/34550428 http://dx.doi.org/10.1007/s00259-021-05542-6 |
| _version_ | 1784642905948815360 |
|---|---|
| author | Roy, Sudipta Whitehead, Timothy D. Li, Shunqiang Ademuyiwa, Foluso O. Wahl, Richard L. Dehdashti, Farrokh Shoghi, Kooresh I. |
| author_facet | Roy, Sudipta Whitehead, Timothy D. Li, Shunqiang Ademuyiwa, Foluso O. Wahl, Richard L. Dehdashti, Farrokh Shoghi, Kooresh I. |
| author_sort | Roy, Sudipta |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8803622 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88036222022-02-02 Correction to: Co‑clinical FDG‑PET radiomic signature in predicting response to neoadjuvant chemotherapy in triple‑negative breast cancer Roy, Sudipta Whitehead, Timothy D. Li, Shunqiang Ademuyiwa, Foluso O. Wahl, Richard L. Dehdashti, Farrokh Shoghi, Kooresh I. Eur J Nucl Med Mol Imaging Correction Springer Berlin Heidelberg 2021-09-22 2022 /pmc/articles/PMC8803622/ /pubmed/34550428 http://dx.doi.org/10.1007/s00259-021-05542-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Roy, Sudipta Whitehead, Timothy D. Li, Shunqiang Ademuyiwa, Foluso O. Wahl, Richard L. Dehdashti, Farrokh Shoghi, Kooresh I. Correction to: Co‑clinical FDG‑PET radiomic signature in predicting response to neoadjuvant chemotherapy in triple‑negative breast cancer |
| title | Correction to: Co‑clinical FDG‑PET radiomic signature in predicting response to neoadjuvant chemotherapy in triple‑negative breast cancer |
| title_full | Correction to: Co‑clinical FDG‑PET radiomic signature in predicting response to neoadjuvant chemotherapy in triple‑negative breast cancer |
| title_fullStr | Correction to: Co‑clinical FDG‑PET radiomic signature in predicting response to neoadjuvant chemotherapy in triple‑negative breast cancer |
| title_full_unstemmed | Correction to: Co‑clinical FDG‑PET radiomic signature in predicting response to neoadjuvant chemotherapy in triple‑negative breast cancer |
| title_short | Correction to: Co‑clinical FDG‑PET radiomic signature in predicting response to neoadjuvant chemotherapy in triple‑negative breast cancer |
| title_sort | correction to: co‑clinical fdg‑pet radiomic signature in predicting response to neoadjuvant chemotherapy in triple‑negative breast cancer |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803622/ https://www.ncbi.nlm.nih.gov/pubmed/34550428 http://dx.doi.org/10.1007/s00259-021-05542-6 |
| work_keys_str_mv | AT roysudipta correctiontococlinicalfdgpetradiomicsignatureinpredictingresponsetoneoadjuvantchemotherapyintriplenegativebreastcancer AT whiteheadtimothyd correctiontococlinicalfdgpetradiomicsignatureinpredictingresponsetoneoadjuvantchemotherapyintriplenegativebreastcancer AT lishunqiang correctiontococlinicalfdgpetradiomicsignatureinpredictingresponsetoneoadjuvantchemotherapyintriplenegativebreastcancer AT ademuyiwafolusoo correctiontococlinicalfdgpetradiomicsignatureinpredictingresponsetoneoadjuvantchemotherapyintriplenegativebreastcancer AT wahlrichardl correctiontococlinicalfdgpetradiomicsignatureinpredictingresponsetoneoadjuvantchemotherapyintriplenegativebreastcancer AT dehdashtifarrokh correctiontococlinicalfdgpetradiomicsignatureinpredictingresponsetoneoadjuvantchemotherapyintriplenegativebreastcancer AT shoghikooreshi correctiontococlinicalfdgpetradiomicsignatureinpredictingresponsetoneoadjuvantchemotherapyintriplenegativebreastcancer |